These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
674 related articles for article (PubMed ID: 22410115)
1. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo. Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115 [TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery. Zhan C; Meng Q; Li Q; Feng L; Zhu J; Lu W Chem Asian J; 2012 Jan; 7(1):91-6. PubMed ID: 22072592 [TBL] [Abstract][Full Text] [Related]
4. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery. Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955 [TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo. Zhan C; Qian J; Feng L; Zhong G; Zhu J; Lu W J Drug Target; 2011 Aug; 19(7):573-81. PubMed ID: 21166603 [TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related]
8. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
9. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250 [TBL] [Abstract][Full Text] [Related]
10. The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma. Li J; Gu B; Meng Q; Yan Z; Gao H; Chen X; Yang X; Lu W Nanotechnology; 2011 Oct; 22(43):435101. PubMed ID: 21955528 [TBL] [Abstract][Full Text] [Related]
11. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity. Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114 [TBL] [Abstract][Full Text] [Related]
12. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex. Wang J; Lei Y; Xie C; Lu W; Yan Z; Gao J; Xie Z; Zhang X; Liu M Int J Pharm; 2013 Dec; 458(1):48-56. PubMed ID: 24144951 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Sun X; Pang Z; Ye H; Qiu B; Guo L; Li J; Ren J; Qian Y; Zhang Q; Chen J; Jiang X Biomaterials; 2012 Jan; 33(3):916-24. PubMed ID: 22048008 [TBL] [Abstract][Full Text] [Related]
14. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434 [TBL] [Abstract][Full Text] [Related]
15. Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy. Wang J; Lei Y; Xie C; Lu W; Wagner E; Xie Z; Gao J; Zhang X; Yan Z; Liu M Bioconjug Chem; 2014 Feb; 25(2):414-23. PubMed ID: 24506588 [TBL] [Abstract][Full Text] [Related]
16. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature. Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083 [TBL] [Abstract][Full Text] [Related]
17. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
18. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344 [TBL] [Abstract][Full Text] [Related]
19. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]